TuisABT • NYSE
add
Abbott Laboratories
Vorige sluiting
$112,61
Dagwisseling
$111,80 - $113,61
Jaarwisseling
$89,67 - $121,64
Markkapitalisasie
197,23 mjd USD
Gemiddelde volume
4,50 m
P/V-verhouding
35,67
Dividend-opbrengs
1,94%
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 10,38 mjd | 4,00% |
Bedryfskoste | 3,94 mjd | 3,22% |
Netto inkomste | 1,30 mjd | -5,31% |
Netto winsgrens | 12,55 | -8,93% |
Wins per aandeel | 1,14 | 5,56% |
EBITDA | 2,64 mjd | 6,50% |
Effektiewe belastingkoers | 18,98% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 7,22 mjd | -11,48% |
Totale bates | 73,02 mjd | -0,46% |
Totale aanspreeklikheid | 33,46 mjd | -6,93% |
Totale ekwiteit | 39,56 mjd | — |
Uitstaande aandele | 1,74 mjd | — |
Prys om te bespreek | 4,98 | — |
Opbrengs op bates | 6,30% | — |
Opbrengs op kapitaal | 8,47% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,30 mjd | -5,31% |
Kontant van bedrywe | 1,96 mjd | 62,93% |
Kontant van beleggings | -453,00 m | 62,65% |
Kontant van finansiering | -791,00 m | 38,63% |
Netto kontantverandering | 703,00 m | 153,02% |
Beskikbare kontantvloei | 1,44 mjd | 109,37% |
Meer oor
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. Wikipedia
Gestig
1888
Hoofkwartier
Webwerf
Werknemers
114 000
